Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment

Disease Markers

Volumn 25, Issue 3, 2008, Pages 181-188

  Millán, Mónica ^a   Sobrino, Tomás ^b   Arenillas, Juan Francisco ^a   Rodríguez Yáñez, Manuel ^b   García, María ^c   Nombela, Florentino ^d   Castellanos, Mar ^c   De La Ossa, Natalia Pérez ^a   Cuadras, Patricia ^a   Serena, Joaquín ^c   Castillo, José ^b   Dávalos, Antoni ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Biomarkers; Blood brain barrier disruption; Excitotoxicity; Ferritin; Inflammation; Iron stores; Thrombolysis

Indexed keywords

FERRITIN; FIBRONECTIN; GELATINASE B; GLUTAMIC ACID; INTERLEUKIN 6; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BLOOD SAMPLING; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG INFUSION; EXCITOTOXICITY; FEMALE; FERRITIN BLOOD LEVEL; FIBRINOLYTIC THERAPY; HUMAN; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE PATIENT;

EID: 58149400518     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/380356     Document Type: Article

References (32)

1. T. Aoki, T. Sumii, T. Mori, X. Wang and E.H. Lo, Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury. Mechanical versus embolic focal ischemia in spontaneously hypertensive rats, Stroke 33 (2002), 2711-2771.
2. M. Castellanos, N. Puig, T. Carbonell, J. Castillo, J.M. Martínez, R. Rama and A. Dávalos, Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats, Brain Res 952 (2002), 1-6.
3. M. Castellanos, R. Leira, J. Serena, M. Blanco, S. Pedraza, J. Castillo and A. Dávalos, Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolysis therapy in acute ischemic stroke, Stroke 35 (2004), 1671-1676.
4. M. Castellanos, T. Sobrino, M. Millán, M. García, J. Arenillas, F. Nombela, D. Brea, N. Pérez de la Ossa, J. Serena, J. Vivancos, J. Castillo and A. Dávalos, Serum cellular fibronectin and matrix metalloproteinase-9 predict parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study, Stroke 38 (2007), 1855-1859.
5. M. Castellanos, T. Sobrino, S. Pedraza, O. Moldes, J.M. Pumar, Y. Silva, J. Serena, M. García-Gil, J. Castillo and A. Dávalos, High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke, Neurology (2008), (in press).
6. J. Castillo, A. Dávalos, J. Naveiro and M. Noya, Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke, Stroke 27 (1996), 1060-1065.
7. J. Castillo, A. Dávalos and M. Noya, Progression of ischemic stroke and excitotoxic aminoacids, Lancet 349 (1997), 79-83.
8. A. Cherubini, C. Ruggiero, M.C. Polidori and P. Mecocci, Potential markers of oxidative stress in stroke, Free Radical Biology & Medicine 39 (2005), 841-852.
9. S. Davis, M.A. Helfaer, R.J. Traystman and P.D. Hum, Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs, Stroke 28 (1997), 198-205.
10. A. Davalos, J. Castillo, J. Marrugat, J.M. Fernández-Real, A. Armengou, P. Cacabelos and R. Rama, Body iron stores and early neurological deterioration in acute cerebral infarction, Neurology 54 (2000), 1568-1574.
11. T. Freret, S. Valable, L. Chazalviel, R. Saulnier, E.T. Mackenzie, E. Petit, M. Bernaudin, M. Boulouard and P. Schumann-Bard, Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat, Eur J Neurosci 23 (2006), 1757-1765.
12. Y. Gürsoy-Özdemir, A. Can and T. Dalkara, Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia, Stroke 35 (2004), 1449-1453.
13. 2+ during the reperfusion phase of transient cerebral ischaemia protects rat hippocampus against iron-catalysed postischaemic injury, Clin Exp Pharmacol Physiol, [Epub ahead of print], 2008.
14. O. Hurtado, J. De Cristobal, V. Sanchez, I. Lizasoain, A. Cardenas, M.P. Pereira, M.I. Colado, J.C. Leza, P. Lorenzo and M.A. Moro, Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental stroke, FASEB J 17 (2003), 2082-2084.
15. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM, The neurotoxicity of tissue plasminogen activator, J Cereb Blood Flow Metab 24 (2004), 945-963.
16. H.A. Kontos, Oxygen radicals in cerebral ischemia, Stroke 32 (2001), 2712-2716.
17. V. Larrue, R.R. von Kummer, A. Muller and E. Bluhmki, Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II), Stroke 32 (2001), 438-441.
18. S.H. Mehta, R. Clinton, A. Ergul, A. Tawak and A.M. Dorrance, Neurprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke, Am J Physiol 286 (2004), 283-288.
19. M. Millán, T. Sobrino, M. Castellanos, F. Nombela, J.F. Arenillas, E. Riva, I. Cristobo, M. García, J. Vivancos, J. Serena, M.A. Moro, J. Castillo and A. Dávalos, Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke, Stroke 38 (2007), 90-95.
20. E. Millerot, A.S. Prigent-Tressier, N.M. Bertrand, P.J.C. Faure, C.M. Mossiat, M.E. Giroud, A.G. Beley and C. Marie, Serum ferritin in stroke: a marker of increased body iron stores or stroke severity? J Cereb Blood Flow Metab 25 (2005), 1386-1393.
21. J. Montaner, C.A. Molina, J. Monasterio, S. Abilleira, J.F. Arenillas, M. Ribé, M. Quintana and J́. Alvarez-Sabín, Matrix metalloproteinases-9 pre-treatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke, Circulation 107 (2003), 598-603
22. H. Monyer, D.M. Hartley and D.W. Choi, 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures, Neuron 5 (1990), 121-126.
23. M. Ning, K.L. Furie, W.J. Koroshetz, H. Lee, M. Barron, M. Lederer, X. Wang, M. Zhu, A.G. Sorensen, E.H. Lo and P.J. Kelly, Association between t-pa therapy and raised early matrix metalloprotreinase-9 in acute stroke, Neurology 66 (2006), 1550-1555.
24. A. Patt, I.R. Horesh, E.M. Berger, A.H. Harken and J.E. Repine, Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains, J Pediatr Surg 25 (1990), 224-228.
25. D.E. Pellegrini-Giampietro, G. Cherici, M. Alesiani, V. Carla and F. Moroni, Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage, J Neurosci 10 (1990), 1035-1041.
26. E. Romanos, A.M. Planas, S. Amaro and A. Chamorro, Uric acid reduces brain damage and improves the benefits of rt-pa in a rat model of thromboembolic stroke, J Cereb Blood Flow Metab (2006), 1-7.
27. M.H. Selim and R.R. Ratan, The role of iron neurotoxicity in ischemic stroke, Ageing Research Reviews 3 (2004), 345-353.
28. J. Serena, M. Blanco, M. Castellanos, Y. Silva, J. Vivancos, M.A. Moro, R. Leira, I. Lizasoain, J. Castillo and A. Dávalos, The prediction of malignant cerebral infarction by molecular brain barrier disruption markers, Stroke 36 (2005), 1921-1926.
29. E. Tarkowski, L. Rosengren, C. Blomstrand, C. Wikkelsö, C. Jensen, S. Ekholm and A. Tarkowski, Intrathecal release of pro- and anti-inflammatory cytokines during stroke, Clin Exp Immunol 110 (1997), 492-499.
30. K. Tsuji, T. Aoki, E. Tejima, K. Arai, S.R. Lee, D.N. Atochin, P.L. Huang, X. Wang, J. Montaner and E. Lo, Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia, Stroke 36 (2005), 1954-1959.
31. E. Vila, J. Castillo, A. Dávalos and A. Chamorro, Proinflammatory cytokines and early neurological worsening in ischemic stroke, Stroke 31 (2000), 2325-2329.
32. N. Walhgren, N. Ahmed, A. Dávalos, G.A. Ford, M. Grond, W. Hacke, M.G. Henerici, M. Kaste, S. Kuelkens, V. Larrue, K.R. Less, R.O. Roine, L. Soinne, D. Toni and G. Vanhooren, for the SITS-MOST investigators, Thrombolysis with alteplase for acute ischemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study, The Lancet 369 (2007), 275-282.